Skip to Main content Skip to Navigation


hal-02415080v1  Journal articles
François GuérardJacques BarbetFerid HaddadMichel CherelFrancoise Kraeber-Bodere et al.  Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic, 2015
...
inserm-01809742v1  Journal articles
Françoise Kraeber-BodereClément BaillyMichel ChérelJean-François Chatal. ImmunoPET to help stratify patients for targeted therapies and to improve drug development
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2016, 43 (12), pp.2166-2168. ⟨10.1007/s00259-016-3458-6⟩
hal-01111285v1  Journal articles
Pierre-Yves SalaunLoïc CampionCatherine AnsquerEric FrampasCédric Mathieu et al.  ¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2014, 41 (8), pp.1501-1510